Rallybio

Drug Discovery

Rallybio is a private drug discovery company. It has raised $145 million across 1 recorded round; the latest was a $145 million Series B in May 2020.

PMV mark · valuation
—
Oct 2026
Priced at
—
Total raised
$145.0M
Last round
Early Stage VC (Series B)
May 2020
How much has Rallybio raised?
$145.0Macross 1 recorded rounds · May 2020 – May 2020

Most recently, Rallybio raised $145.0M in its Early Stage VC (Series B) (May 2020).

Free account
More of Rallybio with a free account
  • ·Watch Rallybio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Rallybio round by round

1 rounds
May 2020Early Stage VC (Series B)$145.0M▮
+ 1 more investors · free account

How much has Rallybio raised?

Rallybio has raised $145 million across 1 recorded round since 2020. The largest was a $145 million Series B in May 2020.

Rallybio has filed 1 Form D with the SEC, most recently in Apr 2024 ($6.6 million sold to 1 investor).

Frequently asked about Rallybio

How much has Rallybio raised?
Rallybio has raised $145.0M in total across 1 recorded funding rounds.
When was Rallybio's last funding round?
Rallybio's most recent recorded round was Early Stage VC (Series B) in May 2020, raising $145.0M.